MAPT and Alzheimer disease: The PCA/SVM results (Fig. 2) revealed that CSF Aβ42, p-tau, and t-tau, could be used to differentiate probable NPH from AD and normal controls with a reasonable sensitivity and specificity (i.e. 90% and 98%, respectively).